A critical discovery in cancer study is arising with the use of mini-antibodies to re-engage damaged p53. This essential tumor inhibitor protein is frequently disabled in various forms of cancer, resulting uncontrolled https://pr7bookmark.com/story22220100/nanobodies-reactivate-p53-new-new-hope-for-cancer-therapy